Bank of New York Mellon Corp - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 156 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$161,000
-48.1%
247,803
+0.0%
0.00%
Q4 2019$310,000
-67.9%
247,802
-67.2%
0.00%
Q3 2019$966,000
-64.1%
754,729
-3.3%
0.00%
-100.0%
Q2 2019$2,693,000
-29.2%
780,658
+4.0%
0.00%0.0%
Q1 2019$3,804,000
+39.5%
750,425
-0.6%
0.00%0.0%
Q4 2018$2,726,000
-38.3%
755,221
+0.5%
0.00%0.0%
Q3 2018$4,416,000751,1790.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 64,315$326,0000.69%
PERKINS CAPITAL MANAGEMENT INC 130,600$662,0000.44%
Senvest Management, LLC 1,000,140$5,071,0000.38%
Matarin Capital Management, LLC 827,462$4,195,0000.30%
DELTEC ASSET MANAGEMENT LLC 271,543$1,377,0000.30%
GLOBEFLEX CAPITAL L P 214,103$1,086,0000.23%
TSP Capital Management Group, LLC 58,050$294,0000.15%
Spark Investment Management LLC 538,443$2,729,0000.13%
Connor, Clark & Lunn Investment Management Ltd. 3,134,905$15,894,0000.10%
FIRST QUADRANT LLC/CA 245,756$1,246,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders